Inventor
ULRICH RODECK
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides50%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C12NMicroorganisms or enzymes13%
PatentTitleYear
11,926,652CTLA4-binding protein peptide-linker masks202411,311,622Development of masked therapeutic antibodies to limit off-target effects202211,279,752Tumor-selective CTLA-4 antagonists202211,186,642Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to HOPE CITY (4)· patent assignee history
2021–2022Patents assigned to UNIV JEFFERSON (3)· patent assignee history
2021–2024Based in US· patent location history
2024Patents assigned to THOMAS JEFFERSON UNIV AND HEALTH SYSTEM INNOVATION PILLAR (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HOPE CITY | 4 | 2021–2024 |
| UNIV JEFFERSON | 3 | 2021–2022 |
| THOMAS JEFFERSON UNIV AND HEALTH SYSTEM INNOVATION PILLAR | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2021–2024 |